Characteristic | Â | Â |
---|---|---|
Eye level |  | N = 113 |
Laterality | Right (%) | 58 (51.33) |
 | Left (%) | 55 (48.67) |
Classification | PDME (%) | 38 (33.63) |
 | NPDME (%) | 75 (66.37) |
CST, µm | Mean (SD) | 478 (172) |
 | Median (IQR) | 443 (205) |
Interval between 1st and 3rd treatments, days | Mean (SD) | 98.17 (44.57) |
Median (IQR) | 76 (56) | |
Participant level |  | N = 82 |
Sex | Male (%) | 56 (68.29) |
 | Female (%) | 26 (31.71) |
Age, years | Mean (SD) | 54 (10) |
 | Median (IQR) | 55 (11.00) |
HbA1c, % | Mean (SD) | 7.60 (1.28) |
 | Median (IQR) | 7.35 (1.76) |
Eye involvement | Unilateral (%) | 51 (62.20) |
 | Bilateral (%) | 31 (37.80) |